AMBIT BIOSCIENCES CORP's ticker is AMBI and the CUSIP is 02318X100. A total of 49 filers reported holding AMBIT BIOSCIENCES CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,540,000 | – | 100,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 2,079,569 | $20,047,000 | 19.47% |
| GREAT POINT PARTNERS LLC | 732,600 | $7,063,000 | 4.99% |
| Redmile Group, LLC | 545,985 | $5,263,000 | 0.65% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,995 | $2,256,000 | 0.63% |
| WEXFORD CAPITAL LP | 530,861 | $5,118,000 | 0.44% |
| Eventide Asset Management | 74,100 | $714,000 | 0.22% |
| Orbimed Advisors | 1,490,769 | $14,371,000 | 0.21% |
| Baker Brothers Advisors | 747,954 | $7,210,000 | 0.10% |
| Artal Group S.A. | 250,000 | $2,410,000 | 0.09% |
| BAILARD, INC. | 35,000 | $337,000 | 0.05% |